Brainstorm Cell Therapeutics CEO Anthony S. Fiorino bought 1,200 shares of the stock on the open market in a transaction dated Monday, September 15th. The stock was purchased at an average cost of $0.28 per share, for a total transaction of $336.00.
http://ift.tt/1qNIsXk
http://ift.tt/1qNIsXk
No comments:
Post a Comment